-
Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
Moon Shot Stocks and a NASA Affiliation: Ascent Solar Technologies: Nas daq: ASTI; Intuitive Machines: Nas daq: LUNR and AST SpaceMobile: Nas daq: ASTS. Read more
-
NASA / Glenn Research Center Collaboration to Help Meet Rising Demand for Space Energy Beaming Tech / CIGS PV Modules from Ascent Solar: NAS DAQ: ASTI
Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI is Positioned to Serve the Rapidly Expanding $1 Trillion Global Space Economy Projected by 2040. Read more
-
Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount
$CYCU Has Signed an MOU to Acquire Video Solutions Division of Kustom Entertainment to Enhance Integrated Public Safety and AI Cybersecurity Solutions. Read more
-
Market Value Enhancement From 2 Important New US Patents Issued for Strengthening Hair Enzyme Booster Technology to Caring Brands (NAS DAQ: CABR)
Caring Brands Inc. (N A S D A Q: CABR) $CABR Has Revenues From Enzyme Booster for Hair Loss, and Photocil for Psoriasis and Vitiligo via Sales in the US and Licensees in India. Read more
-
$80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
Acquisition of Kustom Entertainment, Inc. (N A S D A Q: KUST) to Enhance Integrated Public Safety for Cycurion, Inc. (N A S D A Q: CYCU): Clients and Partners Include: US Dept. of Defense, Defense Intelligence Agency, Dept. of Homeland Security, US Navy a. Read more
-
High-Impact Mental Health Platform Approaching a Defining Regulatory Moment: Eclipsing 70,000 Patients on Real World Use of Ketamine: N ASDAQ: NRXP
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP has Entered into a Joint Offering with neurocare Group for Neuroplastic Therapy Targeting Depression, PTSD and Other Mental Health Afflictions. Read more
-
Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
Caring Brands Inc. (N A S D A Q: CABR) $CABR Intends to Launch 5 Products Over the Next 2 Years in Addition to In-Licensing Additional Products.. Read more
-
AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
BullFrog AI Holdings, Inc. (N A S D A Q: BFRG) $BFRG Published Whitepaper Titled "AI in Bioinformatics: Turning Complex Data into Actionable Insights with BullFrog Data Networks®". Read more
-
IQSTEL Enters 2026 from a Position of Strength Following Transformational Year Marked by N A S D A Q Uplisting, Record Revenue and First-Ever
IQSTEL, Inc. (N A S D A Q: IQST) $IQST Reports $12.23 in Assets per Share and $4.66 in Equity Per Share! Undervalued by Dollars.. Read more
-
AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Receives High-Profile Industry Recognition, Expanding Government Contracts, and Strengthening Financial Position Highlight CYCU's Growth Trajectory. Read more
-
Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
First Procedures Performed in Florida by $CDIX Demonstrate Commitment to Best-in-Class Healthcare for Underserved Traumatic Injury Populations. Read more
-
Record Revenues, Debt-Free Momentum & Shareholder Dividend Ignite Investor Attention Ahead of 2026–2027 Growth Targets: IQSTEL (N A S D A Q: IQST)
IQSTEL, Inc. (N A S D A Q: IQST) $IQST Reports Record Q3 2025 Results with $102.8 Million Quarterly Revenue, 42% Sequential Growth and Strengthened Balance Sheet.. Read more
-
$80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
Cycurion, Inc. (N A S D A Q: CYCU) $CYCU and IQSTEL (N A S D A Q: IQST) $IQST Strengthen Alliance by Retaining $1,000,000 Worth of Cross Holdings and Distribution of $500,000 of Shares to Their Own Shareholders. Read more
-
High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application. Read more
-
FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP; $750 Million Market for Suicidal Depression Market Awaits. Read more
-
AI, Fintech, and Cybersecurity Divisions Ignite High-Margin Growth: IQSTEL, Inc. (N A S D A Q: IQST)
$430 Million 2026 Revenue Forecast for $IQST, 26% Organic Growth, and $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story. Read more
-
Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
$NRXP Has Manufactured Multiple Commercial Lots of NRX-100 and KETAFREE™ with a Shelf Life of Three Years.. Read more
Your online source of trusted news